Melanoma Research Alliance (Mra): Rosetrees Trust-Mra Uk or Israel-Based Young Investigator Award

Supports research that focus on unmet clinical needs in melanoma: • Identifying strategies to overcome primary and secondary treatment resistance;• Developing treatment strategies for difficult-to-treat melanoma subtypes; • Uncovering novel mechanisms of melanoma initiation and progression in order to improve prevention and early detection strategies;• Developing strategies to prevent and/or treat metastatic disease. Pre-clinical, translational, clinical, and/or correlative studies are alowed. Funding: up to $225,000 for 3 years.

https://www.curemelanoma.org/assets/Uploads/MRA-2020-2021-RFP-FINAL.pdf